Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Market Pulse

Daily · Nov 5, 2026 · data.go.kr + ECOS

KOSPI

5,383.80

-300.00 (-5.28%)

KOSDAQ

678.41

-36.54 (-5.11%)

KOSPI 200

837.78

-51.47 (-5.79%)

USD/KRW

1,342.10

Home›Reports›207940

207940KOSPI·Jan 23, 2025

Globally leading CDMO in terms of growth and margins

Samsung BiologicsMirae Asset SecuritiesSeung-min Kim

Read original PDF ↗

Source: Mirae Asset Securities
Type: Company Analysis
Language: English
Rating: Buy
Target price: -
Collected: May 06, 2026

The full report is published by Mirae Asset Securities. Korean Tickers provides its source link and metadata.

More research on 207940

Order concerns ease as growth drivers expandMirae Asset Securities · Jul 27, 2026 Initiating Coverage: Unwavering Growth, Time to Build ConvictionKB Securities · May 27, 2026 Fair value of W106trMirae Asset Securities · Nov 24, 2025 Spin-off likely to unlock additional valueMirae Asset Securities · Oct 29, 2025 Positioning for the next leg of growthMirae Asset Securities · Jul 25, 2025 CDMO and biosimilar businesses to be separatedMirae Asset Securities · May 23, 2025

All reports for 207940 →

Advertisement

Korean Tickers·Research reference for Korean listed companies.

Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.

KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources

Terms Refunds Disclaimer Privacy